BioBytes: AI-Related Deals In Q4 ‘24
The last quarter of 2024 was flush with venture financings for biotechs finding novel ways to incorporate AI into their processes.
The last quarter of 2024 was flush with venture financings for biotechs finding novel ways to incorporate AI into their processes.